Agile Therapeutics
AGRX
$0.38
Share price
-5.47%
Change (1 day)
-90.94%
Change (1 year)
Categories
Market capitalization of Agile Therapeutics (AGRX)
Market cap: $2.58 Million
As of May 2024 Agile Therapeutics has a market cap of $2.58 Million. This makes Agile Therapeutics the world's 8324th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Agile Therapeutics from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $2.58 M | -47.13% |
| 2023 | $4.89 M | -46.88% |
| 2022 | $9.21 M | -84.44% |
| 2021 | $59.25 M | -76.39% |
| 2020 | $0.25 B | 43.78% |
| 2019 | $0.17 B | 781.54% |
| 2018 | $19.79 M | -78.47% |
| 2017 | $91.96 M | -43.9% |
| 2016 | $0.16 B | -24.74% |
| 2015 | $0.21 B | 90.35% |
| 2014 | $0.11 B |
End of Day market cap according to different sources
On May 18th, 2024 the market cap of Agile Therapeutics was reported to be:
$0.94 Million
$2.58 Million
$2.58 Million
$2.58 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $372.16 B | 14,371,590.71% | 🇺🇸 USA |
 Pfizer PFE | $162.29 B | 6,266,939.85% | 🇺🇸 USA |
 Merck MRK | $332.27 B | 12,831,210.08% | 🇺🇸 USA |
 TherapeuticsMD TXMD | $25.6 M | 888.64% | 🇺🇸 USA |
 Antares Pharma ATRS | $0.95 B | 36,780.73% | 🇺🇸 USA |